Acumen Pharmaceuticals (ABOS) Stock Price
Acumen Pharmaceuticals Price
Revenue at Acumen Pharmaceuticals has contracted by 8.0% per year over the past 2 years to 1.44 M USD. For Acumen Pharmaceuticals, the net margin of -7,006.0% is down versus -465.9% a few years ago. The consensus 12-month price target for Acumen Pharmaceuticals is 7.00 USD, about 185.1% above where the stock trades today. Of 12 analysts, 11 rate the stock a buy — an overall Buy consensus.
Acumen Pharmaceuticals stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Acumen Pharmaceuticals business model & stock analysis
Frequently asked questions about Acumen Pharmaceuticals
Analysts currently set an average price target of 7.00 USD for the Acumen Pharmaceuticals stock (median: 7.00 USD), implying +185.1 % versus the latest price. The consensus is based on 12 analyst ratings.
12 analysts currently rate the Acumen Pharmaceuticals stock: 11 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Acumen Pharmaceuticals share trades at 2.20 EUR (2.45 USD).
The Acumen Pharmaceuticals share (ABOS) is listed on 1 stock exchanges, including: NASDAQ (ABOS).
The revenue cannot currently be calculated for Acumen Pharmaceuticals.
The expected profit of Acumen Pharmaceuticals is -98.15 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Acumen Pharmaceuticals is currently -1.51. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Acumen Pharmaceuticals stock.
The P/S cannot be calculated for Acumen Pharmaceuticals currently.
The Eulerpool Quality Score for Acumen Pharmaceuticals is 4/10.
The ISIN of Acumen Pharmaceuticals is US00509G2093. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Acumen Pharmaceuticals is ABOS. The ticker symbol is used to trade Acumen Pharmaceuticals shares on the stock exchange.
Acumen Pharmaceuticals stock
Acumen Pharmaceuticals Peer Group
Acumen Pharmaceuticals Ticker
Acumen Pharmaceuticals FIGI
All fundamentals and in-depth analysis of Acumen Pharmaceuticals
Our stock analysis for Acumen Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acumen Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.